SLVCX Performance — Saratoga Large Capitalization Value Portfolio, Class C
Data updated: 2026-07-24
SLVCX returned +1.56% year to date and +8.49% over one year to May 2026. Annualised returns are +13.67% over 3 years and +7.71% over 5 years. The fund trailed its US Mid-Cap Value category average: $100 invested three years ago grew to $147, against $154 for the category, and to $108 over one year, against $121. Volatility over the past three years was 14.34% a year. In the 12 months to May 2026 the fund lost a net $3.1M, and assets reached $15.20M.
SLVCX Growth of $100
What $100 invested in Saratoga Large Capitalization Value Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | SLVCX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $108 | $121 |
| 3 years (Jun 2023 – May 2026) | $147 | $154 |
| 5 years (Jun 2021 – May 2026) | $145 | $148 |
| Since data start (Mar 2020 – May 2026) | $212 | $217 |
SLVCX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.56% |
| 1 year | +8.49% |
| 3 years (annualised) | +13.67% |
| 5 years (annualised) | +7.71% |
SLVCX Annual Returns
Calendar-year total returns of Saratoga Large Capitalization Value Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +1.56% |
| 2025 | +14.72% |
| 2024 | +5.92% |
| 2023 | +19.08% |
| 2022 | −7.93% |
| 2021 | +27.93% |
| 2020 (Mar–Dec) | +22.69% |
SLVCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.3% | +2.4% | −8.8% | +5.5% | −0.1% | — | — | — | — | — | — | — |
| 2025 | +3.7% | −0.8% | −4.2% | +1.9% | +7.0% | +3.8% | +0.8% | +0.9% | −1.3% | −1.4% | +4.1% | −0.2% |
| 2024 | −0.9% | +4.8% | +2.5% | −5.1% | +2.2% | −2.0% | +5.6% | −1.4% | +1.7% | +0.8% | +2.5% | −4.3% |
| 2023 | +10.1% | −2.4% | −5.6% | −0.7% | −0.7% | +9.6% | +2.3% | −1.8% | −4.5% | −3.6% | +8.1% | +8.7% |
| 2022 | −4.2% | +2.4% | +1.8% | −7.0% | +0.6% | −6.2% | +9.9% | −2.6% | −9.0% | +6.1% | +7.2% | −5.1% |
| 2021 | +3.3% | +4.5% | +4.8% | +5.0% | +0.6% | −0.4% | 0.0% | +2.1% | −2.6% | +5.7% | −3.8% | +6.3% |
| 2020 | — | — | −22.0% | +17.2% | +5.0% | +0.9% | +3.5% | +4.3% | −3.7% | +4.9% | +11.9% | +3.8% |
SLVCX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 14.34%
- 3-year Sharpe ratio: 0.64 (vs 4.5% risk-free rate)
- Best month: +9.58% (Jun 2023)
- Worst month: −8.85% (Mar 2026)
SLVCX Fund Flows
Monthly money in and out of Saratoga Large Capitalization Value Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$3.1M
- 12-month gross sales (incl. reinvestments): $3.2M
- Sales ÷ redemptions: 0.51×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $14K | $933K | −$919K |
| Apr 2026 | $15K | $644K | −$629K |
| Mar 2026 | $28K | $648K | −$620K |
| Feb 2026 | $262K | $162K | $101K |
| Jan 2026 | $70K | $325K | −$255K |
| Dec 2025 | $2.3M | $718K | $1.6M |
| Nov 2025 | $52K | $751K | −$699K |
| Oct 2025 | $82K | $282K | −$199K |
| Sep 2025 | $160K | $586K | −$427K |
| Aug 2025 | $58K | $373K | −$315K |
| Jul 2025 | $70K | $357K | −$287K |
| Jun 2025 | $67K | $484K | −$417K |
SLVCX Assets Under Management
Net assets of Saratoga Large Capitalization Value Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $15.20M |
| 2026-02-28 | $18.09M |
| 2025-11-30 | $17.63M |
| 2025-08-31 | $18.67M |
| 2025-05-31 | $18.63M |
| 2025-02-28 | $19.25M |
| 2024-11-30 | $21.06M |
| 2024-08-31 | $20.25M |
| 2024-05-31 | $20.23M |
| 2024-02-29 | $20.80M |
| 2023-11-30 | $20.94M |
| 2023-08-31 | $21.18M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.